Chan et al evaluate outcomes for women treated for epithelial ovarian cancer. They identified risk factors associated with relapse free survival (RFS). The authors are from the University of California San Francisco, Roswell Park Cancer Center, University of California Irvine, Columbia University, Stanford University, Ohio State University and Fox Chase Cancer Center.
